The store will not work correctly when cookies are disabled.
(E)-3-(3,4-Dimethoxylphenyl)-1-(4-ethoxy-2-hydroxy-3-methyl-phenyl)prop-2-en-1-one
ID: ALA4535415
PubChem CID: 155547922
Max Phase: Preclinical
Molecular Formula: C20H22O5
Molecular Weight: 342.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCOc1ccc(C(=O)/C=C/c2ccc(OC)c(OC)c2)c(O)c1C
Standard InChI: InChI=1S/C20H22O5/c1-5-25-17-11-8-15(20(22)13(17)2)16(21)9-6-14-7-10-18(23-3)19(12-14)24-4/h6-12,22H,5H2,1-4H3/b9-6+
Standard InChI Key: MYMDIYRCTBGOIW-RMKNXTFCSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
14.5165 -12.2456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8011 -12.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0857 -12.2456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5165 -11.4201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2321 -12.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9475 -12.2456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6588 -12.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6588 -13.4817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9475 -13.8965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2321 -13.4817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3742 -12.2456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9475 -11.4201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3742 -13.8965 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3742 -14.7220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0897 -15.1327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3702 -12.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3702 -13.4817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6548 -13.8965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9435 -13.4817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9435 -12.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6548 -12.2456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2279 -13.8965 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5125 -13.4817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6548 -14.7220 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9435 -15.1327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
1 4 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
5 10 2 0
7 11 1 0
6 12 1 0
14 15 1 0
13 14 1 0
8 13 1 0
1 5 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
16 21 2 0
22 23 1 0
19 22 1 0
24 25 1 0
18 24 1 0
3 16 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 342.39 | Molecular Weight (Monoisotopic): 342.1467 | AlogP: 4.01 | #Rotatable Bonds: 7 |
Polar Surface Area: 64.99 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.54 | CX Basic pKa: ┄ | CX LogP: 4.63 | CX LogD: 4.40 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.61 | Np Likeness Score: 0.17 |
References
1. Schwikkard S, Whitmore H, Sishtla K, Sulaiman RS, Shetty T, Basavarajappa HD, Waller C, Alqahtani A, Frankemoelle L, Chapman A, Crouch N, Wetschnig W, Knirsch W, Andriantiana J, Mas-Claret E, Langat MK, Mulholland D, Corson TW.. (2019) The Antiangiogenic Activity of Naturally Occurring and Synthetic Homoisoflavonoids from the Hyacinthaceae ( sensu APGII)., 82 (5): [PMID:30951308] [10.1021/acs.jnatprod.8b00989] |